home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Antibody Drug Discovery: From Target Validation to Candidate Selection

 
  August 28, 2023  
     
 
Xtalks, online
2023 -8-29


This webinar will provide an overview of the antibody discovery process highlighting the critical steps involved in developing effective antibody-based therapeutics. The goal is to guide the audience through the different stages of antibody drug discovery, shedding light on the latest advancements, methodologies and challenges encountered along the way. In addition, the webinar will cover Benchling’s Antibody Solution Accelerator, a set of ready-to-use configurations necessary to capture the process of drug discovery.
 
Throughout the webinar, attendees will gain valuable insights into how Benchling’s Antibody Solution Accelerator supports the critical elements of antibody discovery, ensuring a more streamlined and successful drug development process. Register now to learn best practices for target identification, screening, lead selection and in vivo safety and efficacy.
 
 
Organized by: Xtalks
Invited Speakers: Vega Shah, PhD, Senior Product Marketing Manager, Benchling Sanjay Saraf, Product Manager, Benchling
 
Deadline for Abstracts: 2023 -8-29
 
Registration: Free registration
E-mail: ajuurinen@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.